SCHEMBL18263365

SCHEMBL18263365

Cc1cc(OCCCN)ccc1F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CARM1 Q86X55 1/20 0.48
▸ PDIA6 Q15084 1/20 0.47
▸ PDK2 Q15119 1/20 0.41
▸ NOS3 P29474 1/20 0.41
▸ NOS1 P29475 1/20 0.41
▸ NOS2 P35228 1/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ DRD4 P21917 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ MMP13 P45452 1/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ HTR2A P28223 2/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ MAOB P27338 1/20 0.38
▸ AOC3 Q16853 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5988421 0.93 PDIA6 (0.49) CARM1PDIA6NOS3NOS1NOS2
SCHEMBL21601187 0.91 CARM1 (0.45) CARM1PDIA6PDK2MMP13SMN1; SMN2
SCHEMBL14474330 0.87 MCL1 (0.46) CARM1PDIA6DRD2DRD4DRD3
SCHEMBL21894123 0.87 MMP13 (0.50) CARM1PDIA6DRD2DRD4DRD3
SCHEMBL8100144 0.85 DRD2 (0.54) CARM1PDIA6NOS3NOS1NOS2
SCHEMBL8437066 0.84 TP53 (0.46) CARM1PDIA6PDK2DRD2DRD4
SCHEMBL23473367 0.83 PTGS1 (0.45) PDIA6PDK2KMT2AMEN1HTR2A
SCHEMBL14084030 0.82 MAOB (0.53) PDK2MAOBAOC3FFAR1
SCHEMBL8257779 0.81 CYP3A4 (0.45) PDIA6PDK2MMP13SMN1; SMN2HTR2A
SCHEMBL13177803 0.81 CARM1 (0.48) CARM1PDIA6PDK2NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180162862-A1 INHIBITORS OF BACTERIAL GLYCOSYL TRANSFERASES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-06-14 — — US disclosed
EP-3303338-A1 INHIBITORS OF BACTERIAL GLYCOSYL TRANSFERASES President and Fellows of Harvard College (US) 2018-04-11 — — EP disclosed
WO-2016191658-A1 INHIBITORS OF BACTERIAL GLYCOSYL TRANSFERASES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180162862-A1 INHIBITORS OF BACTERIAL GLYCOSYL TRANSFERASES SI, UGGT1, ALPI CARM1 4371/4885PDIA6 1850/4885PDK2 1500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback